Find your next paid study

University of MiamiNCT05352061

Actual pay is set by the research site.

Exercise-Induced Ankle-Brachial Index Dynamics as a Predictive Marker in Peripheral Arterial Disease

The goal of this observational study or clinical trial is to investigate how exercise can affect different areas of a person's life, especially those people wi…

Peripheral Arterial Disease(PAD)

Louisiana State University Health Sciences Center ShreveportNCT07637396

Actual pay is set by the research site.

Phase 2

Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)

Phase II open label study designed to evaluate the efficacy and safety of P-Sam in patients with aggressive, solid, NOTCH mutant or p63 low (B7-H4 high) R/M AC…

Adenoid Cystic Carcinoma

M.D. Anderson Cancer CenterNCT07162480

~$75 – $2,000

Actual pay is set by the research site.

Phase 2

The Efficacy of Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) Combined With CURativE Intent Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients. A Multicentre, Randomised, Open-label Phase-II Study

The goal of this randomized clinical trial is to investigate whether pressurized intraperitoneal chemotherapy (PIPAC), delivered immediately after minimally in…

Gastric CancerChemotherapy, AdjuvantPeritoneal Metastases+1 more

Odense University HospitalNCT06295094

~$75 – $2,000

Actual pay is set by the research site.

Advanced Solid TumorsNon-Small Cell Lung Cancer

A First-in-Human, Multicenter, Open-Label, Phase 1/2a Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CKD-703 in Advanced c-Met Expressing Solid Tumors, and in MET Amplified and c-Met Overexpressing Non-Small Cell Lung Cancer

This is a Phase 1/2a open-label multicenter study to evaluate the safety, efficacy, and pharmacokinetics of CKD-703 in Advanced c-Met Expressing Solid Tumors, …

Chong Kun Dang PharmaceuticalNCT07439094

~$150 – $4,200

Actual pay is set by the research site.

A Multi-center, Open-label, Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of YL205 in Patients With Advanced Solid Tumors

This study is a multicenter, open-label, phase I/II study of YL205 in China to evaluate the safety, tolerability, PK characteristics and preliminary efficacy o…

Advanced Solid Tumors

MediLink Therapeutics (Suzhou) Co., Ltd.NCT06459973

~$150 – $4,200

Actual pay is set by the research site.

Advanced Solid TumorMetastatic Cancer

STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Study

This is a non-randomized two-arm trial, specifically a pilot study in which patients with advanced solid tumor cancer with 3-10 metastatic lesions who are on i…

University of Illinois at ChicagoNCT07269080

~$150 – $3,000

Actual pay is set by the research site.

Qutenza 8% Capsaicin Topical System for the Treatment of Neuropathic Axial Lower Back Pain and Lumbosacral Radiculopathy: A Prospective Study.

This is a research study to find out if Qutenza 8% capsaicin topical system is safe and effective when treating subjects with lower back pain (LBP) that is cau…

Lower Back PainLumbosacral Radiculopathy

Medical University of South CarolinaNCT06540456

Actual pay is set by the research site.

Phase 4

Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment

The purpose of this study is to identify individuals 18 or older who have diagnostic presentation of adhesive capsulitis and randomize them into two arms, dist…

Adhesive CapsulitisFrozen ShoulderShoulder Frozen

Massachusetts General HospitalNCT02283996

~$25 – $1,000

Actual pay is set by the research site.

Recurrent High Grade GliomaAnaplastic AstrocytomaAnaplastic Oligodendroglioma+2 more

A Phase I Study of Metronomic Temozolomide With Abexinostat (PCI-24781) for Patients With Recurrent High Grade Glioma

Glioblastoma (GBM), WHO grade IV glioma, represents the majority of adult malignant primary brain tumors, with an incidence of 2-3 per 100,000 person-years. Th…

University of NebraskaNCT05698524

~$150 – $3,000

Actual pay is set by the research site.

Phase 4

Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking During Abstinence

Tobacco use is the leading cause of preventable death in the U.S., with 480,000 deaths per year and 7.7 million deaths globally. A major clinical symptom assoc…

SmokingNicotineTobacco+4 more

Legacy Health SystemNCT07328594

~$25 – $1,000

Actual pay is set by the research site.

Observational

Adapting the RDAD Intervention for Individuals With Down Syndrome Phase 3- Pilot Test

The goal of this clinical trial is to observe feasibility and initial efficacy of a remotely delivered exercise and dementia caregiving intervention in older a…

Down Syndrome (DS)Alzheimer's Disease (AD)